Navigation Links
Profectus BioSciences Inc. Names Shawn Patrick O'Brien CEO
Date:1/28/2008

New leadership brings biotech and large pharma experience to lead

commercialization phase for a leading AIDS/HIV R&D company

BALTIMORE, Jan. 28 /PRNewswire/ -- Profectus BioSciences Inc., a biotechnology company that develops preventative and therapeutic technologies to reduce the morbidity and mortality of viral diseases, today announced that its board of directors has appointed Shawn Patrick O'Brien as the company's president and chief executive officer. O'Brien will also serve as a director of the company. The appointment comes as Profectus BioSciences enters the commercialization phase of operations.

To date, Profectus BioSciences has a unique relationship with the Institute of Human Virology (http://www.IHV.org), along with other academic and government institutions to gain access to breakthrough technologies focused on the treatment and prevention of AIDS/HIV. Currently, the Company has five technology platforms and two commercialization partners to progress the development of its AIDS vaccine for human and veterinary use. The Company plans to work with other commercialization partners to progress the other four promising technology platforms in the treatment of AIDS/HIV.

O'Brien has extensive global experience in business development, sales, licensing, and R&D at biotech and large pharma companies. He comes to Profectus BioSciences from Solstice Neurosciences Inc., where he served as president and chief executive officer since 2004. During his tenure at Solstice, O'Brien increased key sales by 90 percent, opened the EU market with new partners and patents, addressed unsettled patent issues and expanded the clinical development program to include six investigational new drugs (INDs).

Previously, O'Brien worked with AstraZeneca USA as vice president of commercial operations for emerging brands, and as vice president and therapy area leader for the respiratory and infla
'/>"/>

SOURCE Profectus BioSciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ANGHAI, Dec. 1 /PRNewswire-Asia/ -- Shanghai ChemP... a leading China-based Contract Research,Organizat...009 Deloitte,Technology Fast 50 China, ranking 3rd...anies in China. The award is a testament to ChemPa... 2006 to 2008. , The results of the 2009 ...
(Date:12/1/2009)...NGFIELD, Ill., Dec. 1 Prairie Hear...ce that it was recently awarded two statuettes at .... 13 in New York City. The CLIO Healthcare Awards ...he healthcare advertising industry and is an exten...ecognized awards competitions for advertising, des...
(Date:12/1/2009)... Enterprise level storage is now available t...hout breaking the bank. , ...w.pacsdrive.com ), a medical imaging software com...ble cloud storage service. The PacsDrive service e...s to securely archive medical imaging in complianc...
(Date:12/1/2009)... Congruent Software agrees to migrate their ...ccounting clients) to Synergy Business Solutions t... Seattle, WA (PRWEB) December 1, 2009 -- Syner...red the Microsoft Dynamics SL practice of Congruen...vider. The move was necessary due to a change in C...
Breaking Biology Technology:Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3
...2 /PRNewswire-FirstCall/ . Maxygen, Inc.,(Nasdaq: ...velopment of,improved protein drugs, today reporte...r ended December 31, 2007. At December 31, 2007, c...taled $145.8 million compared to,$182.9 million at... MAXY-G34 in the clinic, we enter 2008 in a,solid ...
...Keck Graduate Institute,(KGI) today announced that...nology Industry Organization (BIO), will discuss "... Race: Who Will Regulate, Who Will,Innovate?" at t...ies on,Wednesday, March 26, 2008, at 4 pm., "We a...rve as our guest,speaker at this year,s event," sa...
...ounced, SILVER SPRING, Md., Feb. 12 United,Thera...ay that it will,release its 2007 fourth quarter an...et on Tuesday, February 19, 2008., United Therape...day,February 19, 2008, at 9:00 a.m. Eastern Time. ...3-1777, with international callers dialing,+1-706-...
Other Biology Technology:Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 2Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 3Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 4Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 5Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 6KGI Announces BIO President Greenwood to Address Health Care Reform and the Presidential Race at Simon Ramo Lecture 2KGI Announces BIO President Greenwood to Address Health Care Reform and the Presidential Race at Simon Ramo Lecture 3
(Date:12/2/2009)...niversity of Salamanca and another from Yale Unive...fects the behaviour of Acanthodactylus beersheben...e Near East. According to the study, these reptile...ey if they are under pressure from predators. , ... but until now there had been very few experimenta...
(Date:12/2/2009)...N, NJ According to the National Institute of Heal...d with diabetes already have some stage of diabeti...e retina caused by leaky blood vessels, is a major... one of the most feared diabetic complications. I...d diabetes for 10 years or more will experience so...
(Date:12/1/2009)...s National Primate Research Center, Emory Universi...ic prairie voles, an important step toward unlocki...e application of this technology will enable scien...hat will help identify the brain mechanisms of soc...is advancement may also have important implication...
Breaking Biology News(10 mins):Lizards change their diet to avoid predators 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3Yerkes researchers create first transgenic prairie voles 2Video 3A Plan for Long Term Care Before the Crisis Hits 47797 1Video 3A Plan for Long Term Care Before the Crisis Hits 47797 2Video 3A Plan for Long Term Care Before the Crisis Hits 47797 3Video 3A Plan for Long Term Care Before the Crisis Hits 47797 4Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 1Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 3Stepping up minority recruiting 47791 1Stepping up minority recruiting 47791 2Stepping up minority recruiting 47791 3
...icant advance for regenerative medicine, researche... culture adult stem cells from bone marrow such th...at is rich in important biochemical growth factors...n the Proceedings of the National Academy of Scien...esearchers found they could coax bone cells into p...
...rcher Yvonne van Breugel analysed rocks from seabe...in two stable forms; atomic mass 12 (99 percent) a...assic and Cretaceous periods were characterised by... have shown that this was caused by a sudden large... ocean floor or peats and bogs. , The atmospheric...
...have identified a handful of microRNAs (miRNAs) th...pment of platelets ?blood cells critical to the bo...ey also say some of these same miRNAs, when acting...ukemia. , "Basically, we found that a specific set...development, but turned on in certain platelet-rel...
Other Biology News:Findings advance use of adult stem cells for replacement bone 2Carbon cycle was already disrupted millions of years ago 2MiRNA fingerprint identified in platelet formation 2
RNaseZAP(r) from Sigma-Aldrich
Sinapic acid from Sigma-Aldrich
Corning Culture Flask, 25 cm2, Tc-Treated, Straight Neck, Vent Cap, Sterile from Sigma-Aldrich
...iginally developed at the USDA Insect Pathology La...gation of cells from the fall armyworm,Spodoptera ...rowth and maintenance of cell lines derived from l...se cell lines. One of the most significant uses of...
Biology Products: